Susquehanna International Group
SIOX

Susquehanna International Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Susquehanna International Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-34,900
Closed -$23K – 14393
2022
Q1 		$23K Sell
34,900
-25,600
-42% -$21.7K ﹤0.01% 12591
2021
Q4 		$78K Buy
60,500
+600
+1% +$1.06K ﹤0.01% 12305
2021
Q3 		$130K Sell
59,900
-15,300
-20% -$33.3K ﹤0.01% 11898
2021
Q2 		$205K Sell
75,200
-28,900
-28% -$71.9K ﹤0.01% 11553
2021
Q1 		$272K Sell
104,100
-60,400
-37% -$171K ﹤0.01% 10813
2020
Q4 		$457K Buy
164,500
+69,300
+73% +$202K ﹤0.01% 8492
2020
Q3 		$440K Buy
95,200
+57,200
+151% +$189K ﹤0.01% 7942
2020
Q2 		$107K Sell
38,000
-100
-0.3% -$321 ﹤0.01% 9466
2020
Q1 		$93K Sell
38,100
-155,300
-80% -$561K ﹤0.01% 9372
2019
Q4 		$990K Sell
193,400
-40,500
-17% -$225K ﹤0.01% 5548
2019
Q3 		$1.51M Sell
233,900
-124,400
-35% -$858K ﹤0.01% 4798
2019
Q2 		$2.23M Buy
358,300
+329,562
+1,147% +$2.51M ﹤0.01% 3948
2019
Q1 		$306K Buy
28,738
+15,475
+117% +$154K ﹤0.01% 7182
2018
Q4 		$106K Sell
13,263
-24,200
-65% -$349K ﹤0.01% 8192
2018
Q3 		$725K Sell
37,463
-18,937
-34% -$345K ﹤0.01% 5870
2018
Q2 		$1.02M Buy
56,400
+23,212
+70% +$342K ﹤0.01% 5319
2018
Q1 		$353K Sell
33,188
-30,275
-48% -$486K ﹤0.01% 7348
2017
Q4 		$2.68M Sell
63,463
-91,162
-59% -$4.09M ﹤0.01% 3419
2017
Q3 		$8.51M Buy
154,625
+63,825
+70% +$10.8M ﹤0.01% 1918
2017
Q2 		$16.8M Buy
90,800
+66,212
+269% +$11.6M 0.01% 1281
2017
Q1 		$2.94M Buy
24,588
+14,600
+146% +$1.53M ﹤0.01% 3068
2016
Q4 		$992K Buy
9,988
+4,663
+88% +$491K ﹤0.01% 5558
2016
Q3 		$596K Buy
5,325
+2,712
+104% +$326K ﹤0.01% 5738
2016
Q2 		$268K Buy
+2,613
New +$261K ﹤0.01% 7145
2016
Q1 		– Sell
-1,350
Closed -$195K – 9863
2015
Q4 		$195K Sell
1,350
-3,850
-74% -$501K ﹤0.01% 8446
2015
Q3 		$537K Buy
+5,200
New +$610K ﹤0.01% 6985

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Susquehanna International Group's SIOX Position: Q1 2023 in Review

Susquehanna International Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 95,387 shares — an estimated $41.5K sold.

Susquehanna International Group first reported a position in SIOX in Q3 2015 and held it in 21 quarters. The position peaked at $1.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Susquehanna International Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 95,387 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $41.5K.
  • Susquehanna International Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 21 quarters.
  • Susquehanna International Group's Sio Gene Therapies Inc. Common Stock position peaked at $1.1M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.